Micronized Acellular Dermal Matrix

It is a donor-derived human dermal material processed to remove cells and selected immune components while retaining extracellular matrix such as collagen structure. The material is sterilized, processed into particles, and reconstituted for injection. It provides a scaffold and soft-tissue volume, but integration and clinical results vary.

Donor screening, decellularization, sterilization, manufacturing controls, and lawful Taiwan registration are important safeguards, but no implanted or injected medical material is risk-free. Possible risks include swelling, bruising, infection, inflammation, nodules, asymmetry, poor integration, and vascular complications. Ask the clinic which registered product will be used and review its instructions and risks with the physician.

Sheet ADM is generally placed surgically as a graft or soft-tissue support over a broader area, sometimes around an implant. Micronized ADM is processed into particles, reconstituted, and injected through a needle or cannula for smaller or more detailed areas. They differ in form, placement, indications, and risks.

Possible areas include selected hollows of the forehead or temples, nasal bridge, chin, cheeks, nasolabial folds, and some fine static lines. Use around the nose and eyes requires particular caution because of vascular anatomy. Suitability depends on the product instructions, tissue condition, prior implants or fillers, and physician assessment.

Fat grafting uses your own harvested fat and can restore larger volumes across multiple areas, but it requires a donor-site procedure and retention is assessed after the graft stabilizes. Micronized ADM is donor-derived, can provide immediate volume in selected smaller areas, and does not require fat harvesting. The better option depends on the amount needed, treatment area, donor fat, downtime, implant preferences, and individual risks.

Duration varies with the specific material, treatment area, amount, preparation, tissue integration, and individual response. Micronized ADM should not be described as permanently or semi-permanently retained for every patient. Your physician should explain the evidence and expected range for the registered product actually used.

People with allergy or hypersensitivity to the selected product, active systemic or treatment-site infection, active inflammation, or certain immune conditions may not be suitable. Pregnancy, breastfeeding, severe allergy history, keloid tendency, cardiovascular disease, anticoagulant use, and significant psychiatric illness require individual assessment. Tell the physician about prior surgery, implants, fillers, medicines, and supplements. Do not stop prescribed aspirin or anticoagulants without consulting the prescriber.

Redness, swelling, tenderness, itching, or bruising can occur and often improves over several days. Follow the clinic’s instructions for cleansing, makeup, skincare, activity, alcohol, heat exposure, saunas, steam rooms, and swimming. Avoid pressing or massaging the area unless instructed. Contact the clinic for worsening pain, marked redness, fever, drainage, skin-color changes, visual symptoms, or other concerning changes.

Temporary bruising, redness, swelling, tenderness, asymmetry, or palpable material can occur. Other possible complications include infection, inflammation, nodules, poor integration, migration, tissue injury, and vascular occlusion. Injections around the nose or eyes can rarely cause serious skin or visual complications. Seek urgent assessment for severe or worsening pain, pale or mottled skin, or any visual symptoms.